Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy model
Open Access
- 1 November 2004
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 22 (6), 1261-1270
- https://doi.org/10.1016/j.orthres.2004.03.014
Abstract
This study evaluated healing of rabbit bilateral ulnar osteotomies 6 and 8 weeks after surgery in response to percutaneous injection of transgenic adenoviral (Ad) bone morphogenetic protein‐6 (BMP‐6) vector or green fluorescent protein vector control (Ad‐GFP) administered 7 days after surgery compared to untreated osteotomy controls. The amount, composition and biomechanical properties of the healing bone repair tissue were compared among groups and to historical data for intact rabbit ulnae obtained from similar studies at the same institution. Quantitative computed tomography was used to determine area, density and mineral content of the mineralized callus in the harvested ulnae. Maximum torque, torsional stiffness, and energy absorbed to failure were determined at 1.5°/s. Calcified sections of excised ulnae (5 μm) were stained with Goldner's Trichrome and Von Kossa, and evaluated for callus composition, maturity, cortical continuity, and osteotomy bridging. Radiographic assessment of bone formation indicated greater mineralized callus in the ulnae injected with Ad‐hBMP‐6 as early as 1 week after treatment (2 weeks after surgery) compared to untreated osteotomy ulnae (P < 0.006) and Ad‐GFP treated osteotomy ulnae (p < 0.002). Quantitative computed tomography confirmed greater bone area and bone mineral content at the osteotomy at 6 weeks in Ad‐BMP‐6 treated osteotomy as compared to untreated osteotomy ulnae (p < 0.001) and Ad‐GFP treated osteotomy ulnae (p < 0.01). Ad‐BMP‐6 treated osteotomy ulnae were stronger (p < 0.001 and 0.003) and stiffer (p = 0.004 and 0.003) in torsion at 6 weeks than untreated osteotomy ulnae or Ad‐GFP treated osteotomy ulnae, respectively. Maximum torque, torsional stiffness, and energy absorbed to failure were greater in Ad‐BMP‐6 treated osteotomy ulnae compared to their respective untreated contralateral osteotomy ulnae at 8 weeks [p < 0.03]. Maximum torque and torsional stiffness in the Ad‐BMP‐6 treated osteotomy ulnae were not different to intact ulnae values at 6 and 8 weeks. These experiments confirm that BMP‐6 can be potently osteoinductive in vivo resulting in acceleration of bone repair. © 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.Keywords
This publication has 64 references indexed in Scilit:
- Bone consolidation is enhanced by rhBMP‐2 in a rabbit model of distraction osteogenesisJournal of Orthopaedic Research, 2002
- Adenovirus mediated gene transfer to skeletal muscleMicroscopy Research and Technique, 2002
- Increased Bone Morphogenetic Protein-6 Expression in Mouse Long Bones After Estrogen AdministrationJournal of Bone and Mineral Research, 2002
- Recombinant Human Bone Morphogenetic Protein-2 Enhances Osteotomy Healing in Glucocorticoid-Treated RabbitsJournal of Bone and Mineral Research, 2002
- The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog modelJournal of Orthopaedic Research, 2001
- Molecular aspects of healing in stabilized and non‐stabilized fracturesJournal of Orthopaedic Research, 2001
- Osteoinductive Applications of Regional Gene TherapyClinical Orthopaedics and Related Research, 2000
- Osteoinduction by Bone Morphogenetic Protein-2 via Adenoviral Vector under Transient ImmunosuppressionBiochemical and Biophysical Research Communications, 2000
- Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal valuesJournal of Neurosurgery, 1999
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998